BioIntelliSense Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 89

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $58.3M

  • Investors
  • 18

BioIntelliSense General Information

Description

Developer of a remote patient monitoring device designed to enhance healthcare delivery. The company's device provides continuous, passive monitoring of vital signs and biometrics through medical-grade wearable devices with actionable health insights and supporting early intervention, enabling healthcare providers to improve patient outcomes, streamline clinical workflows and reduce hospital readmissions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 17301 West Colfax Avenue
  • Suite 152
  • Golden, CO 80401
  • United States
+1 (888)
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 17301 West Colfax Avenue
  • Suite 152
  • Golden, CO 80401
  • United States
+1 (888)

BioIntelliSense Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioIntelliSense Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series C) 01-Jun-2026 $58.3M Completed Generating Revenue
6. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
5. Early Stage VC (Series B1) 30-Dec-2022 Completed Generating Revenue
4. Early Stage VC (Series B) 28-Jul-2021 Completed Generating Revenue
3. Grant 24-Dec-2020 Completed Generating Revenue
2. Early Stage VC (Series A1) 08-Sep-2020 $12M $37M Completed Generating Revenue
1. Early Stage VC (Series A) 17-May-2019 $25M $25M Completed Generating Revenue
To view BioIntelliSense’s complete valuation and funding history, request access »

BioIntelliSense Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B1
Series B-1-1
Series B
Series A-1 2,540,939 $0.000100 $0.38 $4.72 $4.72 1x $4.72 7.85%
Series A 9,999,066 $0.000100 $0.2 $2.5 $2.5 1x $2.5 30.89%
To view BioIntelliSense’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

BioIntelliSense Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a remote patient monitoring device designed to enhance healthcare delivery. The company's device provides c
Monitoring Equipment
Golden, CO
89 As of 2026

Noida, India
 

Snoqualmie, WA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioIntelliSense Competitors (52)

One of BioIntelliSense’s 52 competitors is Agatsa, a Venture Capital-Backed company based in Noida, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Agatsa Venture Capital-Backed Noida, India
Spacelabs Healthcare Corporate Backed or Acquired Snoqualmie, WA
CardioDiagnostics Private Equity-Backed Campbell, CA
CloudTag Formerly PE-Backed Kingstown, Saint Vincent
ZOLL Medical Corporate Backed or Acquired Chelmsford, MA
You’re viewing 5 of 52 competitors. Get the full list »

BioIntelliSense Patents

BioIntelliSense Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260080977-A1 Biological programming language Pending 20-Jun-2024
US-20250391498-A1 Protein latent structure traversal Pending 20-Jun-2024
US-20250378901-A1 Protein refinement and joint optimization Pending 07-Jun-2024
US-12367329-B1 Protein binder search Active 06-Jun-2024
US-20260161853-A1 Protein binder search Pending 06-Jun-2024 G06F30/27
To view BioIntelliSense’s complete patent history, request access »

BioIntelliSense Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioIntelliSense Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Confluent Corporation
Dexcom Ventures Corporate Venture Capital Minority
Fresenius Medical Care Ventures Corporate Venture Capital Minority
TLG Capital Management PE/Buyout Minority
Chimera Capital PE/Buyout Minority
You’re viewing 5 of 18 investors. Get the full list »

BioIntelliSense Acquisitions (1)

BioIntelliSense’s most recent deal was a Merger/Acquisition with AlertWatch. The deal was made on 18-Oct-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
AlertWatch 18-Oct-2022 Merger/Acquisition Decision/Risk Analysis
To view BioIntelliSense’s complete acquisitions history, request access »

BioIntelliSense Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
AlertWatch Ann Arbor, MI 2011

BioIntelliSense FAQs

  • When was BioIntelliSense founded?

    BioIntelliSense was founded in 2019.

  • Where is BioIntelliSense headquartered?

    BioIntelliSense is headquartered in Golden, CO.

  • What is the size of BioIntelliSense?

    BioIntelliSense has 89 total employees.

  • What industry is BioIntelliSense in?

    BioIntelliSense’s primary industry is Monitoring Equipment.

  • Is BioIntelliSense a private or public company?

    BioIntelliSense is a Private company.

  • What is BioIntelliSense’s current revenue?

    The current revenue for BioIntelliSense is .

  • How much funding has BioIntelliSense raised over time?

    BioIntelliSense has raised $319M.

  • Who are BioIntelliSense’s investors?

    Confluent, Dexcom Ventures, Fresenius Medical Care Ventures, TLG Capital Management, and Chimera Capital are 5 of 18 investors who have invested in BioIntelliSense.

  • Who are BioIntelliSense’s competitors?

    Agatsa, Spacelabs Healthcare, CardioDiagnostics, CloudTag, and ZOLL Medical are some of the 52 competitors of BioIntelliSense.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process